How do you win hospital tenders and rebate contracts without eroding your margin on price alone?
We support pharma, biotech, MedTech and IVD manufacturers operationally through procurement procedures run by statutory health insurers and hospitals, from assessing whether the tender documents can be scored, through bid pricing, into the negotiation room. The real leverage rarely lies in the lowest price: those who read the contracting authority's scoring matrix early and substantiate non-price criteria such as supply reliability and service levels win tenders that a pure price war would have lost.
- Pharma
- Biotech
- MedTech
- IVD
Overview
What rules govern tenders and negotiations in the statutory health insurance system?
Senior consultants in the negotiation room · procurement law GWB Part 4, rebate contracts SGB V § 130a, aids supply contracts SGB V § 127
Last updated: 2026-06-13
Procurement procedures run by statutory health insurers and public hospitals do not follow free negotiation but the public procurement law set out in the Act against Restraints of Competition (GWB). Anyone who does not understand the rules of the procedure before submitting a bid loses not on price but on formal errors and on a scoring matrix they failed to read. Four points are decisive:
- Above the EU thresholds under GWB § 106, the formal procedure under Part 4 GWB and the Public Procurement Regulation (VgV) is mandatory; the procedure type and the contract notice set out deadlines and formal requirements that are non-negotiable.
- Rebate contracts for medicinal products under SGB V § 130a Abs. 8 are regularly tendered as active-substance-based formal procurement procedures under Part 4 GWB, exclusive or non-exclusive, with the award going to a limited number of suppliers.
- Aids supply contracts under SGB V § 127 follow a different logic: they are concluded through negotiations with an opt-in option, and the health insurer must allow every provider to take part in the contract negotiations. This is not a classic tender procedure but an open negotiation route.
- The award goes to the most economically advantageous tender, not necessarily the cheapest. Award criteria alongside price, such as supply reliability, service levels and quality evidence, are set out in the contract notice and must be substantiated in the bid.
Services
How we support you
Tender Document Analysis & Eligibility Review
Making the contract notice and tender documents readable: procedure type under Part 4 GWB, eligibility and exclusion grounds, deadlines and the scoring matrix. The outcome is an eligibility and risk report with a bid/no-bid recommendation before submission.
Bid & Pricing Strategy
Costing the bid along the award criteria, so not only price but the non-price criteria weighted in the contract notice. The outcome is a documented price floor with a margin corridor and substantiated scoring arguments.
Rebate Contract Support (Pharma)
Operational support for active-substance-based tenders under SGB V § 130a Abs. 8, both exclusive and non-exclusive. The outcome is a compliant, deadline-conforming bid including verified eligibility evidence.
Negotiation Support for MedTech & Aids
Support for contract negotiations under SGB V § 127 with an opt-in option. Senior consultants are present directly in the negotiation room and secure service levels, prices and contract terms. The outcome is a negotiated contract with documented terms.
Learn more →Win/Loss Analysis
A structured review of won and lost procedures: where the award went, which award criteria were decisive, where your own bid was weak. The outcome is an action plan for the next tendering round.
How we work together
What it comes down to
In the statutory health insurance system, a tender is not a free sales conversation but a procedure with fixed rules. Above the EU thresholds under GWB § 106, the contract notice sets out the procedure type, the deadlines and the award criteria; what is not stated there does not count in the scoring, and what is required there decides exclusion ahead of any price. The order is therefore fixed: first read the scoring matrix and the eligibility requirements, then set the price floor in line with the type of award, and only then write the bid. Anyone who starts with the price is calculating against a target they do not yet know.
The second bottleneck lies in the procedural logic itself. Rebate contracts under SGB V § 130a Abs. 8 are formal procurement procedures with a hard award to a few suppliers, and the question of exclusive versus non-exclusive shifts the expected volume so strongly that the same price floor holds in one case and not in the other. Aids supply contracts under SGB V § 127, by contrast, follow an open negotiation route with an opt-in option, in which it is not the single best bid that wins but the fully negotiated terms that count. This is exactly where our senior consultants sit in the negotiation room: so that service levels and supply reliability enter the contract as substantiated scoring arguments and not as a concession out of the margin.
Our approach
Our approach
Step
Result
Review the tender documents
Eligibility and risk report: procedure type, deadlines, scoring matrix and exclusion grounds are assessed, bid/no-bid is decided.
Set the bid strategy
Defined price floor with a margin corridor and prioritized non-price arguments aligned to the award criteria.
Prepare the bid
Compliant, deadline-conforming bid with complete eligibility evidence and substantiated scoring arguments.
Conduct the negotiation
Supported negotiation; for contracts under SGB V § 127, a negotiated contract with documented terms.
Debrief & win/loss
Review of the procedure outcome and an action plan for the next round.
Common pitfalls
Where projects commonly fail
The scoring matrix is not read before the price is calculated.
The award goes to the most economically advantageous tender under Part 4 GWB. Anyone who ignores the weighting of the non-price criteria calculates the margin away and still does not win.
Formal errors and deadlines disqualify before any substantive scoring.
In the formal procedure under the Public Procurement Regulation (VgV), incomplete eligibility evidence or missed submission deadlines lead to exclusion, regardless of how strong the bid is on the merits.
Pharma and MedTech procedures are lumped together.
Rebate contracts under SGB V § 130a Abs. 8 are formal procurement procedures with a hard award; aids supply contracts under SGB V § 127 are open negotiations with an opt-in option. Anyone who confuses the procedural logic prepares the wrong bid.
Exclusive and non-exclusive are not distinguished.
For rebate contracts under SGB V § 130a Abs. 8, the type of award fundamentally changes the expected sales volume; a price floor without that assumption is not robust.
Lost procedures are not analysed.
Without a win/loss analysis it remains unknown whether price, eligibility or a scoring criterion was decisive. The same mistake is then repeated in the next tendering round.
FAQ
Frequently asked questions
Sources
- Gesetz gegen Wettbewerbsbeschränkungen (GWB), Part 4, primary text, § 106 (EU thresholds)
- Vergabeverordnung (VgV), primary text
- Directive 2014/24/EU on public procurement, primary text
- SGB V § 130a Abs. 8 and § 127, primary text (Sozialgesetzbuch Fünftes Buch, German Social Code Book V)
- https://theentourage.de/expertise/tender-negotiation-support/ (existing page content, revised)
Life Science Journal
Regulatory updates, straight to your inbox.
New requirements, authority decisions and practice notes. Once a month, unsubscribe any time.
Case Studies
What this looks like in practice
Regulations & standards considered
- Gesetz gegen Wettbewerbsbeschränkungen (GWB), Part 4 (German Act against Restraints of Competition, public procurement)
- GWB § 106 (EU thresholds)
- Vergabeverordnung (VgV) (German Public Procurement Regulation)
- Directive 2014/24/EU (public procurement)
- SGB V § 130a Abs. 8 (rebate contracts for medicinal products)
- SGB V § 127 (contracts for medical aids)
Have a concrete project?
Briefly outline your situation. We'll respond with an initial assessment, usually within one business day.
Prefer direct? +49 89 4161170-0
info@theentourage.de
- Reply usually within one working day
- 4 offices: DE · CH · IT · US
- 100% life sciences